Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus
- 1 September 2004
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (5) , 1047-1052
- https://doi.org/10.1016/j.jacc.2004.05.071
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- Screening for treatable left ventricular abnormalities in diabetic patientsExpert Opinion on Biological Therapy, 2003
- Utility of B-Natriuretic Peptide in Detecting Diastolic DysfunctionCirculation, 2002
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Brain natriuretic peptide predicts mortality in the elderly.Heart, 1997
- Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registryThe American Journal of Cardiology, 1996
- Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.Journal of Clinical Investigation, 1995
- Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)The American Journal of Cardiology, 1991
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974